Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients
- PMID: 20377768
- DOI: 10.1111/j.1440-1797.2009.01162.x
Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients
Abstract
Aim: Long-term peritoneal dialysis (PD) may lead to peritoneal fibrosis and ultrafiltration failure. It had been demonstrated that the renin-angiotensin system (RAS) plays a key role in the regulation of peritoneal function in rats on PD. We investigated the effects of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) on long-term PD patients.
Methods: We analyzed data from 66 patients treated with PD therapy at our centre for at least 12 months retrospectively, during which time at least two peritoneal equilibration tests (PET) were performed. Thirty-eight patients were treated with ACE/angiotensin II (AII) inhibitors (ACE/ARB group); the other 28 received none of the above drugs during the entire follow up (control group). The expression of fibronectin, transforming growth factor-beta1 (TGF-beta1), Aquaporin1 (AQP1) and vascular endothelial growth factor (VEGF) in the overnight effluent were examined by enzyme-linked immunosorbent assay.
Results: The demographic data of the two groups showed no difference during the study. No difference between the groups was found with respect to residual renal function (RRF) at the start for both groups by the end of follow up, decreased in the vast majority of patients from both groups (P = 0.014). After 12 months, a significant difference in ultrafiltration was found between the two groups: in the control group it had decreased, while it had not changed in the ACE/ARB group (P < 0.05). In comparison with the baseline level, expression of fibronectin, TGF-beta1 and VEGF in dialysate effluent were significantly increased except for AQP1 in the control group (P < 0.05), but not in the ACE/ARB group (P > 0.05).
Conclusion: The findings suggest that ACE/AII inhibitors appeared to have a slower rate of decline in ultrafiltration and RRF, effectively protect against peritoneal fibrosis in long-term peritoneal dialysis. Long-term follow up seems to be required to draw more conclusions.
Similar articles
-
Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.Nephrol Dial Transplant. 2008 Nov;23(11):3704-10. doi: 10.1093/ndt/gfn321. Epub 2008 Jun 20. Nephrol Dial Transplant. 2008. PMID: 18567695
-
A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients.Nephrol Dial Transplant. 2009 Jan;24(1):272-7. doi: 10.1093/ndt/gfn421. Epub 2008 Jul 30. Nephrol Dial Transplant. 2009. PMID: 18676349
-
Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.Perit Dial Int. 2007 Jul-Aug;27(4):446-53. Perit Dial Int. 2007. PMID: 17602154
-
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.
-
Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.Neth J Med. 2010 Jan;68(1):15-23. Neth J Med. 2010. PMID: 20103817 Review.
Cited by
-
Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells.Kidney Res Clin Pract. 2015 Jun;34(2):83-92. doi: 10.1016/j.krcp.2015.03.005. Epub 2015 Apr 25. Kidney Res Clin Pract. 2015. PMID: 26484027 Free PMC article.
-
I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.J Bras Nefrol. 2025 Jan-Mar;47(1):e20240033. doi: 10.1590/2175-8239-JBN-2024-0033en. J Bras Nefrol. 2025. PMID: 40009791 Free PMC article.
-
Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis.Int J Biochem Cell Biol. 2016 Aug;77(Pt B):240-50. doi: 10.1016/j.biocel.2016.04.016. Epub 2016 May 7. Int J Biochem Cell Biol. 2016. PMID: 27167177 Free PMC article. Review.
-
Valsartan ameliorates high glucose-induced peritoneal fibrosis by blocking mTORC1 signaling.Exp Biol Med (Maywood). 2020 Jun;245(11):983-993. doi: 10.1177/1535370220919364. Epub 2020 May 14. Exp Biol Med (Maywood). 2020. PMID: 32408765 Free PMC article.
-
Effectiveness of Renin-Angiotensin-Aldosterone System Blockade on Residual Kidney Function and Peritoneal Membrane Function in Peritoneal Dialysis Patients: A Network Meta-Analysis.Sci Rep. 2019 Dec 20;9(1):19582. doi: 10.1038/s41598-019-55561-5. Sci Rep. 2019. PMID: 31862905 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous